Telomeric DNA mediates de novo pml body formation

Molecular Biology of the Cell

Volumn 20, Issue 22, 2009, Pages 4804-4815

  Brouwer, Anneke K ^a   Schimmel, Joost ^a   Wiegant, Joop C A G ^a   Vertegaal, Alfred C O ^a   Tanke, Hans J ^a   Dirks, Roeland W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROMYELOCYTIC LEUKEMIA PROTEIN;

ARTICLE; CELL DISRUPTION; CELL TYPE; GENE CONTROL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTERPHASE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN INTERACTION; PROTEIN MOTIF; SUMOYLATION; TELOMERE;

ANIMALS; CELLS, CULTURED; DNA; HUMANS; INCLUSION BODIES; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; RECOMBINANT FUSION PROTEINS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 73949118333     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-04-0309     Document Type: Article

References (48)

1. Bernardi, R., and Pandolfi, P. P. (2007). Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell. Biol. 8, 1006-1016.
2. Boisvert, F. M., Hendzel, M. J., and Bazett-Jones, D. P. (2000). Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148, 283-292.
3. Borden, K.L.B. (2002). Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22, 5259-5269.
4. Broccoli, D., Smogorzewska, A., Chong, L., and de Lange, T. (1997a). Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17, 231-235.
5. Broccoli, D., Chong, L., Oelmann, S., Fernald, A. A., Marziliano, N., van Steensel, B., Kipling, D., Le Beau, M. M., and de Lange, T. (1997b). Comparison of the human and mouse genes encoding the telomeric protein, TRF1, chromosomal localization, expression and conserved protein domains. Hum. Mol. Genet. 6, 69-76.
6. Carbone, R., Pearson, M., Minucci, S., and Pelicci, P. G. (2002). PML NBs associate with the hMre11 complex at sites of irradiation induced DNA damage. Oncogene 21, 1633-1640.
7. Chen, Y. C., Kappel, C., Beaudouin, J., Eils, R., and Spector, D. L. (2008). Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis. Mol. Biol. Cell 19, 3147-3162.
8. Conlan, A. L., McNees, C. J., and Heierhorst, J. (2004). Proteasome-dependent dispersal of PML nuclear bodies in response to alkylating DNA damage. Oncogene 23, 307-310.
9. de The, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., and Dejean, A. (1991). The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684.
10. Dellaire, G., and Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays 26, 963-977.
11. Dellaire, G., Eskiw, C. H., Dehghani, H., Ching, R. W., and Bazett-Jones, D. P. (2006a). Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1. J. Cell Sci. 119, 1034-1042.
12. Dellaire, G., Ching, R. W., Dehghani, H., Ren, Y., and Bazett-Jones, D. P. (2006b). The number of PML nuclear bodies increases in early S phase by a fission mechanism. J. Cell Sci. 119, 1026-1033.
13. Dunham, M. A., Neumann, A. A., Fasching, C. L., and Reddel, R. R. (2000). Telomere maintenance by recombination in human cells. Nat. Genet. 26, 447-450.
14. Eskiw, C. H., Dellaire, G., Mymryk, J. S., and Bazett-Jones, D. P. (2003). Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. J. Cell Sci. 116, 4455-4466.
15. Everett, R. D., Earnshaw, W. C., Pluta, A. F., Sternsdorf, T., Ainsztein, A. M., Carmena, M., Ruchaud, S., Hsu, W. L., and Orr, A. (1999a). A dynamic connection between centromeres and ND10 proteins. J. Cell Sci. 112, 3443-3454.
16. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R., and Orr, A. (1999b). Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588.
17. Everett, R. D., and Chelbi-Alix, M. K. (2007). PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89, 819-830.
18. Fasching, C. L., Neumann, A. A., Muntoni, A., Yeager, T. R., and Reddel, R. R. (2007). DNA damage induces alternative lengthening of telomeres (ALT)-associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. Cancer Res. 67, 7072-7077.
19. Henson, J. D., Neumann, A. A., Yeager, T. R., and Reddel, R. R. (2002). Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610.
20. Hu, C.-D., Chinenov, Y., and Kerppola, T. K. (2002). Visualization of interactions among bZIP and Rel proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9, 789-798.
21. Jegou, T., Chung, I., Heuvelman, G., Wachsmuth, M., Görisch, S. M., Greulich-Bode, K. M., Boukamp, P., Lichter, P., and Rippe, K. (2009). Dynamics of telomeres and promyelocytic leukemia nuclear bodies in a telomerase-negative human cell line. Mol. Biol. Cell 20, 2070-2082.
22. Kieβlich, A., von Mikecz, A., and Hemmerich, P. (2002). Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells. J. Struct. Biol. 140, 167-179.
23. Koken, M.H.M., et al. (1994). The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073-1079.
24. Kumar, P. P., Bischof, O., Purbey, P. K., Notani, D., Urlaub, H., Dejean, A., and Galande, S. (2007). Functional interaction between PML and SATB1 regulates chromatin loop architecture and transcription of the MHC class I locus. Nat. Cell Biol. 9, 45-56.
25. Lanotte, M., Martin-Thouvenin, V., Najman, S., Balerini, P., Valensi, F., and Berger, R. (1991). NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77, 1080-1086.
26. Maul, G. G. (1998). Nuclear domain 10, the site of DNA virus transcription and replication. BioEssays 20, 660-667.
27. Maul, G. G., Yu, E., Alexander, M., Ishov, A. M., and Epstein, A. L. (1995). Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J. Cell. Biochem. 59, 498-513.
28. Melnick, A., and Licht, J. D. (1999). Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215.
29. Misteli, T. (2001). Protein dynamics: Implications for nuclear architecture and gene expression. Science 291, 843-847.
30. Molenaar, C., Wiesmeijer, K., Verwoerd, N. P., Khazen, S., Eils, R., Tanke, H. J., and Dirks, R. W. (2003). Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J. 22, 6631-6641.
31. Muratani, M., Gerlich, D., Janicki, S. M., Gebhard, M., Eils, R., and Spector, D. L. (2002). Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat. Cell Biol. 4, 106-110.
32. Naeem, M., Harrison, K., Barton, K., Nand, K. S., and Alkan, S. (2006). A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy. Eur. J. Haematol. 76, 164-166.
33. Nefkens, I., Negorev, D. G., Ishov, A. M., Michaelson, J. S., Yeh, E. T., Tanquay, R. M., Muller, W. E., and Maul, G. G. (2003). Heat shock and CD(2+) exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently. J. Cell Sci. 116, 513-524.
34. Negorev, D., and Maul, G. G. (2001). Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 29, 7234-7242.
35. Ogino, H., Nakabayashi, K., Suzuki, M., Takahashi, E., Fujii, M., Suzuki, T., and Ayusawa, D. (1998). Release of telomeric DNA from chromosomes in immortal human cells lacking telomerase activity. Biochem. Biophys. Res. Comm. 248, 223-227.
36. Potts, P. R., and Yu, H. (2007). The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere binding proteins. Nat. Struct. Mol. Biol. 14, 581-590.
37. Shen, T. H., Lin, -K. H., Scaglioni, P. P., Yung, T. M., and Pandolfi, P. P. (2006). The mechanisms of PML-nuclear body formation. Mol. Cell 24, 331-339.
38. Shiels, C., Islam, S. A., Vatcheva, R., Sasieni, P., Sternberg, M. J., Freemont, P. S., and Sheer, D. (2001). PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J. Cell Sci. 114, 3705-3716.
39. Snaar, S., Wiesmeijer, K., Jochemsen, A. G., Tanke, H. J., and Dirks, R. W. (2000). Mutational analysis of fibrillarin and its mobility in living human cells. J. Cell Biol. 151, 653-662.
40. Spector, D. L. (2001). Nuclear domains. J. Cell Sci. 114, 2891-2893.
41. Vertegaal, A. C., Andersen, J. S., Ogg, S. C., Hay, R. T., Mann, M., and Lamond, A. I. (2006). Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell Proteonom. 5, 2298-2310.
42. Wang, Z. G., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F., and Pandolfi, P. P. (1998). Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547-1551.
43. Wang, J., Shiels, C., Sasieni, P., Wu, P. J., Islam, S. A., Freemont, P. S., and Scheer, D. (2004). Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J. Cell Biol. 164, 515-526.
44. Weis, K., Ramboud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., and Dejean, A. (1994). Retinoic acid regulates aberrant nuclear localization of PML-RARαin acute promyelocytic leukemia. Cell 75, 347-386.
45. Wiesmeijer, K., Krouwels, I. K., Tanke, H. J., and Dirks, R. W. (2008). Chromatin movement visualized with photoactivable GFP-labeled histone H4. Differentiation 76, 83-90.
46. Wiesmeijer, K., Molenaar, C., Bekeer, C. I. M. L. A., Tanke, H. J., and Dirks, R. W. (2002). Mobile foci of SP100 do not contain PML: PML bodies are immobile but PML and SP100 proteins are not. J. Struct. Biol. 140, 180-188.
47. Yeager, T. R., Neumann, A. A., Englezou, A., Huschtscha, L. I., Noble, J. R., and Reddel, R. R. (1999). Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179.
48. Zhong, S., Muller, S., Ronchetti, S., Freemont, P. S., Dejean, A., and Pandolfi, P. P. (2000). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.